Abstract
Because clinical trials are the gold standard for evaluating the safety and efficacy of drugs and medical devices, they should be conducted as safely and objectively as possible. Objectivity can be affected by study design and conduct, but additional risks to objectivity – and possible risks to safety – may arise from financial conflicts of interest (FCOIs). The explosion in recent decades of financial relationships between medical researchers and the pharmaceutical and medical device industry means it is very likely that at least some members of most clinical trial study teams will have a financial tie with the sponsor or manufacturer of the study drug or device. Payments of various types are ubiquitous. The data on payments to physicians published by the Center for Medicare and Medicaid Services (CMS) since 2014 offers evidence that approximately half of all physicians have financial ties with industry (Tringale et al. 2017). Social science studies have demonstrated that financial interests can give rise to conscious or unconscious bias in favor of the product being tested or its manufacturer. In addition, when institutions that are clinical trial sites have financial interests related to a clinical trial, the institutional conflicts of interest (institutional COIs) can create risks to the objectivity or safety of the study. So close attention to conflict of interest issues is essential for protecting the integrity of clinical trials. This chapter will examine the nature of the risks at issue, key regulations and standards for addressing FCOIs in research, key elements of FCOI policies, and approaches to evaluating and addressing FCOIs.
Similar content being viewed by others
References
Ahn R, Woodbridge A, Abraham A et al (2017) Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study. BMJ 356:i6770. https://doi.org/10.1136/bmj.i6770
Bauchner H, Fontanarosa P, Flanagin A (2018) Conflicts of interests, authors, and journals. JAMA 320:2315. https://doi.org/10.1001/jama.2018.17593
Cain D (2008) Everyone’s a little bit biased (even physicians). JAMA 299:2893. https://doi.org/10.1001/jama.299.24.2893
CFR – Code of Federal Regulations Title 21 (2019) In: Accessdata.fda.gov. Accessed 28 Jan 2019
Cigarroa F, Masters B, Sharphorn D (2018) Institutional conflicts of interest and public trust. JAMA 320:2305. https://doi.org/10.1001/jama.2018.18482
Dana J, Loewenstein G (2003) A social science perspective on gifts to physicians from industry. JAMA 290:252. https://doi.org/10.1001/jama.290.2.252
eCFR — Code of Federal Regulations (2019) In: Ecfr.gov. https://www.ecfr.gov/cgi-bin/text-idx?c=ecfr&SID=992817854207767214895b1fa023755d&rgn=div5&view=text&node=42:1.0.1.4.23&idno=42#sp42.1.50.f. Accessed 28 Jan 2019
Friedman J, Sugarman J, Dhillon J et al (2007) Perspectives of clinical research coordinators on disclosing financial conflicts of interest to potential research participants. Clin Trials 4:272–278. https://doi.org/10.1177/1740774507079239
Gottlieb JD (2015) Financial conflicts of interest in research. In: Suckow M, Yates B (eds) Research regulatory compliance. Elsevier Inc., London, pp 253–276
Gottlieb JD, Bressler NM (2017) How should journals handle the conflict of interest of their editors? JAMA 317:1757. https://doi.org/10.1001/jama.2017.2207
Hhs.gov (2016) Financial conflict of interest: HHS guidance (2004). In: HHS.gov. https://www.hhs.gov/ohrp/regulations-and-policy/guidance/financial-conflict-of-interest/index.html#. Accessed 4 Feb 2019
ICMJE | Recommendations | Author Responsibilities—Conflicts of Interest (2019) In: Icmje.org. http://www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities%2D%2Dconflicts-of-interest.html. Accessed 28 Jan 2019
Ioannidis J, Trepanowski J (2018) Disclosures in nutrition research. JAMA 319:547. https://doi.org/10.1001/jama.2017.18571. Available at: https://jamanetwork.com/journals/jama/article-abstract/2666008
Lundh A, Bero L (2017) The ties that bind. BMJ 356:j176. https://doi.org/10.1136/bmj.j176
Lo B, Field MJ (eds) (2009) Principles for identifying and assessing conflicts of interests. In: Conflict of interest in medical research, education, and practice, 1st edn. National Academies Press, Washington, DC, pp 44–61. Available at: https://www.nap.edu/read/12598/chapter/4. Accessed 25 Jan 2019
Stolberg S (2019) Youth’s death shakes new field of gene experiments on humans. In: Archive.nytimes.com. https://archive.nytimes.com/www.nytimes.com/library/national/science/012700sci-gene-therapy.html. Accessed 28 Jan 2019
Tringale K, Marshall D, Mackey T et al (2017) Types and distribution of payments from industry to physicians in 2015. JAMA 317:1774–1784. https://doi.org/10.1001/jama.2017.3091
Wilson RF (2009) Estate of Gelsinger v. Trustees of University of Pennsylvania: Money, Prestige, and Conflicts of Interest In Human Subjects Research. In: Johnson SH, Krause JH, Saver RS, Wilson RF (eds) Health Law and Bioethics: Cases In Context
World Medical Association (2013) World Medical Association declaration of Helsinki. JAMA 310:2191–2194. https://doi.org/10.1001/jama.2013.281053
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Gottlieb, J.D. (2021). Financial Conflicts of Interest in Clinical Trials. In: Piantadosi, S., Meinert, C.L. (eds) Principles and Practice of Clinical Trials. Springer, Cham. https://doi.org/10.1007/978-3-319-52677-5_275-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-52677-5_275-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52677-5
Online ISBN: 978-3-319-52677-5
eBook Packages: Springer Reference MathematicsReference Module Computer Science and Engineering